Feng Huang Wang Cai Jing·2025-09-17 13:41Company News - Novo Nordisk plans to launch an oral version of semaglutide (Wegovy) in the U.S. early next year, highlighting its significant advantages over competitors in the obesity treatment market [2] - GlaxoSmithKline announced a $30 billion investment in the U.S. over the next five years for research and supply chain infrastructure, with $1.2 billion allocated for advanced manufacturing facilities and AI technologies [3] - STMicroelectronics will invest $60 million to upgrade its factory in Tours, France, to establish a pilot production line for advanced semiconductor manufacturing technology known as Panel-Level Packaging (PLP) [4] - Cryptocurrency exchange Bullish has received a BitLicense from the New York Department of Financial Services, allowing it to offer spot trading and custody services to institutional and high-net-worth traders in New York [5]